EMN

Eastman Chemical Company: Q1 2009 10-Q Summary

Business Context and Reporting Period

This filing is a Quarterly Report on Form 10-Q for Eastman Chemical Company for the period ended March 31, 2009. The Company operates in five segments: Coatings, Adhesives, Specialty Polymers, and Inks (CASPI); Fibers; Performance Chemicals and Intermediates (PCI); Performance Polymers; and Specialty Plastics (SP). The reporting period reflects the severe impact of the global economic recession on demand and pricing.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Sales decreased 35% year-over-year, driven by a 25% volume decline and a 9% price decline. Excluding contract sales from divestitures, organic sales fell 30%.
• Profitability Compression: Operating earnings dropped 85% to $25 million. This was significantly impacted by a $26 million restructuring charge for a reduction in force of approximately 300 employees. Excluding restructuring and other non-recurring items, adjusted operating earnings were $51 million, still down 73% from the prior year.
• Segment Performance:
  • PCI Segment: Reported an operating loss of $3 million (vs. $44 million profit in 2008) due to lower volumes and prices in olefin-based derivatives.
  • Performance Polymers: Reported an operating loss of $25 million (vs. $6 million loss in 2008) due to lower selling prices and slower-than-expected start-up of the IntegRex facility.
  • Fibers Segment: Remained the strongest performer with operating earnings of $69 million, slightly up from $68 million, driven by higher selling prices and favorable product mix.
• Cash Flow Improvement: Despite minimal net earnings, operating cash flow turned positive ($82 million) compared to a $53 million outflow in Q1 2008, primarily due to a $70 million reduction in inventory levels.

Guidance, Outlook, and Risks

• 2009 Outlook: Management expects declines in volume due to the global recession and continued volatility in raw material and energy prices. Most segments are expected to face challenges meeting typical operating margins.
• Earnings Guidance: Assuming capacity utilization improves to 75-80% for the remainder of 2009, the Company expects full-year 2009 diluted earnings per share (excluding cost reduction charges) to be between $2.00 and $3.00.
• Capital Spending: Expected to be between $300 million and $350 million for 2009, focused on maintenance and targeted growth (e.g., Tritan copolyester expansion).
• Liquidity: The Company maintains $800 million in credit facilities (with $80 million drawn) and a $200 million accounts receivable securitization program (fully drawn). Management expects to generate positive free cash flow in 2009.
• Risks: Key risks include the severity and duration of the global recession, customer creditworthiness, raw material availability, and the ability to pass on cost increases to customers.

Investor Verification Checklist

• Restructuring Impact: Verify the timing and cash outflow associated with the $26 million severance charge and the expected long-term cost savings.
• Inventory Levels: Confirm that the $76 million reduction in inventory is sustainable and not indicative of future demand destruction.
• Capacity Utilization: Monitor the Company's ability to achieve the 75-80% utilization rate required to meet the $2.00-$3.00 EPS guidance.
• IntegRex Technology: Assess the commercial viability and licensing potential of the IntegRex technology, which is central to the Performance Polymers turnaround strategy.
• Debt Covenants: Review compliance with financial ratios in the $700 million credit facility, particularly given the volatility in earnings.